focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Share News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.65
Bid: 35.30
Ask: 36.00
Change: 2.30 (6.97%)
Spread: 0.70 (1.983%)
Open: 32.70
High: 35.30
Low: 35.30
Prev. Close: 33.00
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Creo device used in 'groundbreaking' lung cancer procedure

Fri, 01st Mar 2024 14:06

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

The AIM-traded company announced that professor Pallav Shah and Dr Christopher Orton, specialists from the Royal Brompton Hospital, had successfully conducted the world's first robotic-guided microwave ablation of lung tissue concurrently with a diagnostic procedure.

It said the pioneering procedure, using its MicroBlate Flex device, targeted a 27mm cancerous nodule within a patient's lung.

The achievement was considered a notable advancement in the medical community's ability to diagnose, stage, and treat lung cancer in a single sitting.

In a statement, Dr Orton emphasised the potential of the innovative approach, saying the "potential to combine the diagnosis, staging, and treatment of lung cancer in one procedure offers significant benefit to patients".

Creo said the procedure, conducted at the Royal Brompton Hospital in London, reportedly lasted just three minutes.

"Creo has been pioneering minimally invasive surgical endoscopy for pre-cancer and cancer patients for years, and implementing our technology into robotic application is a key goal for us as the adoption of this technology continues to grow exponentially," said chief executive officer Craig Gulliford.

"We are incredibly proud that our MicroBlate Flex technology has been able to make this world-first possible.

"The potential for these technologies to combine precise robotically guided lung cancer diagnosis with the ablation of cancerous tissue in one session is transformational."

Gulliford said that could "dramatically improve" outcomes for lung cancer patients, and had the potential to remove "long and worrying" delays between diagnosis and treatment.

"This is the beginning of an exciting programme and the team have done a terrific job in reaching this point."

At 1411 GMT, shares in Creo Medical Group were up 0.84% at 30p.

Reporting by Josh White for Sharecast.com.

More News
30 Jan 2020 14:21

Creo Medical Expects Big 2020 For Speedboat Medical Device

Creo Medical Expects Big 2020 For Speedboat Medical Device

Read more
30 Jan 2020 10:50

Creo Medical progresses with commercialisation of CROMA

(Sharecast News) - Medical device company Creo continued to trade in-line with expectations during 2019, while also making progress in the commercialisation of its CROMA Advanced Energy Platform and a suite of patented electrosurgical devices.

Read more
24 Dec 2019 10:43

DIRECTOR DEALINGS: Creo Medical Non-Exec Chair And Director Buy Shares

DIRECTOR DEALINGS: Creo Medical Non-Exec Chair And Director Buy Shares

Read more
23 Dec 2019 14:17

Creo Medical Raises GBP2 Million From Open Offer, GBP52 Million In All

Creo Medical Raises GBP2 Million From Open Offer, GBP52 Million In All

Read more
16 Dec 2019 16:03

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
4 Dec 2019 17:35

Creo Medical Raises GBP50 Million Through Share Issue

Creo Medical Raises GBP50 Million Through Share Issue

Read more
2 Dec 2019 13:34

Creo Medical Announces Three-Part Fundraise With GBP43 Million Placing

Creo Medical Announces Three-Part Fundraise With GBP43 Million Placing

Read more
20 Nov 2019 13:31

Creo announces first in-human use of 'Speedboat' in India

(Sharecast News) - Medical device company Creo Medical Group announced on Wednesday that the first mentored, in-human use of its 'Speedboat' device had taken place in India.

Read more
20 Nov 2019 13:09

Creo Medical's Speedboat Used In Humans For First Time In India

Creo Medical's Speedboat Used In Humans For First Time In India

Read more
22 Oct 2019 14:54

Full Commercial Launch For Creo Medical's Speedboat Device

Full Commercial Launch For Creo Medical's Speedboat Device

Read more
30 Sep 2019 12:38

Creo Medical Interim Loss Widens On Higher Administrative Expenses

Creo Medical Interim Loss Widens On Higher Administrative Expenses

Read more
26 Sep 2019 13:09

Creo Medical Signs Agreement With Meditek For Product Push In India

Creo Medical Signs Agreement With Meditek For Product Push In India

Read more
23 Sep 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
25 Jun 2019 14:38

Creo Medical Gets 1st Commercial Orders For Speedboat Surgical Device

(Alliance News) - Creo Medical Group PLC on Tuesday said it has received the first commercial orders for its Speedboat medical device.Shares in Creo were up 12% at 187.24 pence in afternoon

Read more
30 May 2019 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Friday 31 MayAG BarrAlba MineralsHostelworldIntu Properties (re KGV transaction with

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.